NGY-B

NGY-B is an investigational **small molecule** oncology program from **Nirogy Therapeutics**. Publicly available information indicates that it is part of Nirogy's pipeline focused on **solute carrier family transporter proteins** and is being developed for **neoplasms**, but the specific active ingredient, molecular structure, precise transporter target, mechanism of action, route, dosage form, and tumor types have not been publicly disclosed. Based on the available company-level description, NGY-B appears to be a targeted cancer therapeutic candidate derived from Nirogy's transporter-focused drug discovery platform, but program-level pharmacology remains undisclosed.